BCLSI
Bain Capital Life Sciences Investors’s Pharvaris PHVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $58.1M | Hold |
3,303,381
| – | – | 7.27% | 4 |
|
2025
Q1 | $51.9M | Hold |
3,303,381
| – | – | 7.67% | 3 |
|
2024
Q4 | $63.3M | Hold |
3,303,381
| – | – | 7.45% | 3 |
|
2024
Q3 | $61.2M | Hold |
3,303,381
| – | – | 6.37% | 6 |
|
2024
Q2 | $62.1M | Hold |
3,303,381
| – | – | 6.82% | 5 |
|
2024
Q1 | $76.3M | Sell |
3,303,381
-600,938
| -15% | -$13.9M | 6.14% | 6 |
|
2023
Q4 | $110M | Sell |
3,904,319
-880,355
| -18% | -$24.7M | 10.5% | 3 |
|
2023
Q3 | $99.9M | Sell |
4,784,674
-84,110
| -2% | -$1.76M | 11.17% | 2 |
|
2023
Q2 | $73.7M | Buy |
4,868,784
+1,688,183
| +53% | +$25.6M | 7.59% | 4 |
|
2023
Q1 | $25.6M | Hold |
3,180,601
| – | – | 3.2% | 11 |
|
2022
Q4 | $35.8M | Hold |
3,180,601
| – | – | 4% | 9 |
|
2022
Q3 | $24.4M | Hold |
3,180,601
| – | – | 2.91% | 12 |
|
2022
Q2 | $70.3M | Hold |
3,180,601
| – | – | 8.24% | 3 |
|
2022
Q1 | $57.7M | Hold |
3,180,601
| – | – | 5.6% | 4 |
|
2021
Q4 | $45.8M | Hold |
3,180,601
| – | – | 3.63% | 9 |
|
2021
Q3 | $56.4M | Hold |
3,180,601
| – | – | 3.5% | 11 |
|
2021
Q2 | $59.3M | Hold |
3,180,601
| – | – | 3.88% | 8 |
|
2021
Q1 | $89M | Buy |
+3,180,601
| New | +$89M | 5.04% | 6 |
|